
From October 1, certain reusable feminine protection products will be reimbursed by Social Security to fight against menstrual poverty.
From October 1, reusable feminine protection sold in pharmacies will be reimbursed by Social Security for women under 26 and beneficiaries of complementary health insurance, in order to combat menstrual poverty.
AI-generated summary
The annual cost of sanitary protection is estimated between 100 and 150 euros per woman.
Certain reusable feminine protections will be reimbursed by Social Security from Thursday October 1st. The measure only concerns products sold in pharmacies and concerns 6.5 million French women. The objective is to fight against menstrual poverty.
For a woman who is menstruating, purchasing pads or tampons costs 100 to 150 euros per year on average. From now on, women under 26, without means requirements, will be able to benefit each year from two menstrual cups or two menstrual panties reimbursed at 60% by Social Security. For beneficiaries of complementary solidarity health insurance, coverage will even be 100%, regardless of age. Many pharmacists report having placed orders for these products, but not all of them have been delivered.
"There are quite drastic specifications. The laboratories which market them must be approved. I think that this will start gradually. The pharmacies will be delivered, but on October 1, it will perhaps be a little tight to come and ask us for them", explains Clarisse Romont who runs La Pharmacie de la gare in Vanves, in Hauts-de-Seine. Indeed, the specifications for these products were published this summer in the Official Journal. It specifies the criteria for the composition and quality of these protections covered by Social Security.
AI outlook — possibilities, not facts
Gradual implementation of pharmacy deliveries
Likely · Within weeks

At a pre-COP31 meeting in Fiji, UN Climate Chief Simon Stiell warned of the increased dangers of extreme heatwaves linked to climate change for pregnant women, associated with premature births, stillbirths, low birth weight and maternal complications, according to a Nature Medicine study and a survey showing that 73% of maternal health professionals observe an increase in these complications.

UN Climate chief Simon Stiell warned Monday at a pre-COP31 meeting in Fiji of increased risks from extreme heat during pregnancy, such as premature births, stillbirths and maternal complications, citing a Nature Medicine study and a survey showing that 73% of maternal health professionals are seeing an increase in such cases.

The Ebola epidemic in the Democratic Republic of Congo has left more than 4,000 dead out of more than 8,000 confirmed cases, according to Congolese authorities. The response is hampered by the presence of armed groups, notably the M23 in North Kivu, and by the mistrust of local populations. French Foreign Minister Jean-Noël Barrot arrived in Bunia to support the response, while France paid 13.4 million euros and the United States a further $267 million.

A petition calling for Nutri-Score to be mandatory on food packaging has exceeded 100,000 signatures. Launched in November 2025 by the scientists behind the system, it aims to influence debates on the 2027 Social Security budget. In addition, an infographic shows the food products whose prices have increased the most despite overall inflation of 3% over one year in September.

Despite the inclusion of abortion in the Constitution in 2024, access to it is deteriorating in France: three out of four women who have had an abortion waited more than seven days for an appointment, compared to 54% in 2024, according to a Family Planning barometer revealed by France Inter. The lack of trained professionals, medical deserts and refusals of support increase territorial and social inequalities.
A study by Que Choisir Ensemble reveals that seven references of matcha tea contain aluminum in significant quantities, with four exceeding the ANSES toxicological reference value. Despite these results, no European regulations limit aluminum in food products, allowing brands to maintain unevaluated health claims.